Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in Her2-expressing Muscle-invasive Bladder Cancer: A Phase II, Open-Label, Randomized Clinical Trial [Phase 2]
This Phase II, open-label, randomized trial assesses two bladder-preserving durations of Disitamab Vedotin plus Toripalimab in HER2-expressi…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection [Phase 2]
Phase 2 trial assessing Disitamab Vedotin combined with a PD-1 inhibitor and radiotherapy as a bladder-preserving treatment for localized HE…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating AM80 in combination with gemcitabine, cisplatin, and nivolumab for urothelial carcinoma; recruitment …
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: MICROBIOTA AND BLADDER CANCER [NA]
This clinical trial update describes a study on the microbiota and bladder cancer sponsored by Centre Hospitalier Universitaire de Nice. The…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. [Phase 1, Phase 2]
This clinical trial explores a tumor immune biomarker-guided strategy to improve response to Bacillus Calmette-Guérin (BCG) therapy in high-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction [Phase 1, Phase 2]
Clinical trial update on eribulin mesylate in patients with locally advanced or metastatic urothelial carcinoma of the bladder, including th…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder [NA]
This clinical trial update reports that the study evaluating cystoscopic evaluation to predict pT0 urothelial carcinoma of the bladder is cu…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer [Phase 2]
A Phase 2 clinical trial is evaluating atezolizumab with etoposide and platinum chemotherapy for small cell bladder cancer and is currently …
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer [Phase 1]
This Phase 1 trial investigates adjuvant concurrent immunotherapy and radiotherapy for bladder cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival Outcomes
This clinical trial update reports on investigating JAM3 as a prognostic biomarker in muscle-invasive urothelial carcinoma (bladder cancer) …
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating 9MW2821 plus toripalimab versus 9MW2821 alone as first-line treatment for locally advanced or metastatic urothelial…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder [Phase 1, Phase 2]
Clinical trial update of intravesical CGC (cabazitaxel, gemcitabine, and cisplatin) for urothelial carcinoma of the bladder, ongoing in Phas…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Bladder Cancer Adjuvant Radiotherapy Trial [Phase 3]
An ongoing Phase 3 adjuvant radiotherapy trial in bladder cancer (urothelial carcinoma of the bladder) is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations [Phase 2]
A Phase 2 clinical trial update assessing sapanisertib in patients with locally advanced or metastatic urothelial carcinoma of the bladder w…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of a PD-1 inhibitor with Clostridium butyricum for urothelial carcinoma of the bladder; cu…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: ALDOA Expression in Bladder Urothelial Carcinoma
A clinical trial update focusing on ALDOA expression in urothelial carcinoma of the bladder; the study is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) [NA]
This clinical trial update describes PreAct, a study evaluating whether preoperative physical activity can be improved by using activity tra…
-
CLINICAL_TRIALS research · 2013-10-28Clinical Trial Update: The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma
Clinical trial update examining the role of pyruvate kinase M2 (PKM2) in the growth, invasion and drug resistance of bladder urothelial carc…